Prof. Yanqiao Zhang 张艳桥
Chief Physician, Professor
Department of Gastroenterology, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Medical oncology for gastrointestinal, lung, breast cancers, and lymphoma using chemotherapy, targeted therapy, and immunotherapy. Performs argon-helium cryoablation for lung, liver, kidney, and soft tissue tumors.
Dr. Zhang is Professor, Chief Physician, Vice President, and Director of Gastroenterology and Biological Therapy at Harbin Medical University Cancer Hospital. Holds a PhD from Harbin Medical University. Completed postdoctoral training at the University of Pittsburgh and was a visiting scholar at Peking University Cancer Hospital.
Professional roles
- Chair, Tumor Biological Therapy Committee, Heilongjiang Anti-Cancer Association
- Vice Chair, Tumor Targeted Therapy Committee, Heilongjiang Province
- Vice Chair, Geriatric Oncology Committee, Heilongjiang Province
- Standing Committee Member, Tumor Targeted Therapy Committee, Chinese Society of Biotechnology
Name order: in Chinese the family name comes first (Zhang Yanqiao). Papers usually list the name as Yanqiao Zhang or Zhang Y.
Selected publications
144 papers on PubMed matched by name and affiliation; 45 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer, 2026 (senior author): Liposomal irinotecan and capecitabine plus bevacizumab as second-line therapy in metastatic colorectal cancer: A multicenter, single-arm study. PubMed 42967221
- Cancer Immunol Res, 2026 (senior author): Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma. PubMed 42462139
- Cancer Sci, 2026 (senior author): A Robust Immunohistochemistry-Based Classification for BRAF V600E-Mutant Colorectal Cancer With Clinical Implications. PubMed 41165126
- Future Oncol, 2025 (senior author): Treatment patterns and outcomes in advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in China. PubMed 40091795
- Cancer Sci, 2025 (senior author): Molecular Subtyping and Genomic Profiling Expand Precision Medicine in KRAS Wild-Type Pancreatic Cancer. PubMed 39833990
- Oncogene, 2025 (senior author): Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer. PubMed 39725712
- Cancer Biol Med, 2025 (senior author): Current status of multiple markers in precision immunotherapy for colorectal cancer. PubMed 40135880
- Cancer Res, 2025 (senior author): Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer. PubMed 39652583
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion